TScan Therapeutics, Inc.
Public company- Headquarters
- WALTHAM, Massachusetts
- Industry
- Biotechnology
- Ticker
- TCRX
- CIK
- 0001783328
WARN notices since 2024
1
First: Sep 2, 2026
Workers affected since 2024
96
Across 1 notice
Executive changes, last 12 months
7
3 appointments, 4 departures
Last event
Oct 16, 2026
Executive departureDirector departs: Garry Nicholson
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| DirectorGarry Nicholson | Oct 16, 2026 | Departed |
| memberStephen Biggar | Oct 16, 2026 | Appointed |
| chairpersonR. Keith Woods | Oct 16, 2026 | Appointed |
| CFOJason A. Amello | Sep 2, 2026 | Departed |
| CMOChrystal Louis, M.D., MPH | Sep 2, 2026 | Departed |
| CEOGavin MacBeath, Ph.D. | Sep 2, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Eloxx Pharmaceuticals, Inc.
director appointed: Geno J. Germano
- Voyager Therapeutics, Inc.
president appointed: Robin Swartz
- Moderna, Inc.
COO appointed: Juan Andres
- REPLIGEN CORP
Board of Directors departs: Karen A. Dawes
layoffs from Nov 2, 2026
WARN noticeWARN notice: Waltham, MA, MA
TScan Therapeutics Inc. (dba TScan) filed a WARN notice with the Massachusetts WARN list covering 96 workers in Waltham, MA. The layoffs take effect on Nov 2, 2026.
Source: Massachusetts WARN list, filed Sep 2, 2026Site: Waltham, MA, MA
Workers affected: 96
Last verified Nov 8, 2026